146 related articles for article (PubMed ID: 36610769)
1. Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost? - Authors' reply.
Chua BH; Link EK; Kunkler IH; Olivotto IA
Lancet; 2023 Jan; 401(10370):24. PubMed ID: 36610769
[No Abstract] [Full Text] [Related]
2. Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost?
Mulliez T; De Ridder M
Lancet; 2023 Jan; 401(10370):23-24. PubMed ID: 36610767
[No Abstract] [Full Text] [Related]
3. Adjuvant Radiation Therapy for Ductal Carcinoma In Situ of the Breast: A Clinician's Dilemma.
Shah C; Vicini F
Ann Surg Oncol; 2023 Oct; 30(11):6281-6283. PubMed ID: 37280311
[No Abstract] [Full Text] [Related]
4. Breast radiotherapy for ductal carcinoma in situ: could less be more?
Coles CE; Chatterjee S; Jagsi R; Kirby AM
Lancet; 2022 Aug; 400(10350):408-410. PubMed ID: 35933995
[No Abstract] [Full Text] [Related]
5. Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast.
Fisher ER
CA Cancer J Clin; 1997; 47(1):52-64. PubMed ID: 8996078
[TBL] [Abstract][Full Text] [Related]
6. Survival benefit of breast-conserving surgery with adjuvant radiotherapy for young women with ductal carcinoma in situ: A population-based cohort study.
Tang J; Wang J; Zhang D; Pan X
Asian J Surg; 2023 Aug; 46(8):3173-3175. PubMed ID: 36898916
[No Abstract] [Full Text] [Related]
7. Ipsilateral breast tumor recurrence after breast-conserving surgery for ductal carcinoma in situ.
Fujita T
Ann Surg; 2011 Jun; 253(6):1233; author reply 1233-4. PubMed ID: 21522008
[No Abstract] [Full Text] [Related]
8. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
[TBL] [Abstract][Full Text] [Related]
9. No Treatment Versus Partial Mastectomy Plus Radiation for Ductal Carcinoma In Situ.
Sun SX; Suk R; Kuerer HM; Cantor SB; Raber BM; Deshmukh AA
Ann Surg Oncol; 2022 Jan; 29(1):39-41. PubMed ID: 34467509
[No Abstract] [Full Text] [Related]
10. Avoiding radiation after breast-conserving surgery for ductal carcinoma in situ of the breast: beyond the margin.
Rourke LL; Hunt KK
Ann Surg; 2010 Apr; 251(4):592-4. PubMed ID: 20224366
[No Abstract] [Full Text] [Related]
11. [Radiotherapy of breast carcinoma. 2005 version].
Organgruppe "Mammakarzinom" der DEGRO
Strahlenther Onkol; 2006 Feb; 182 Suppl 1():4-28. PubMed ID: 16613299
[No Abstract] [Full Text] [Related]
12. Surgical Excision Versus Neoadjuvant Radiotherapy Followed by Delayed Surgical Excision of Ductal Carcinoma In Situ (NORDIS).
Rossi AJ; Verbus EA; Horst K; De Martini W; Allison K; Hernandez JM; Wapnir IL
Ann Surg Oncol; 2022 Mar; 29(3):1528-1529. PubMed ID: 34471985
[No Abstract] [Full Text] [Related]
13. What Can Molecular Diagnostics Add to Locoregional Treatment Recommendations for DCIS?
Shelley Hwang E; Thompson A
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376162
[No Abstract] [Full Text] [Related]
14. Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
De Rose F; De Santis MC; Meduri B; Franzese C; Franceschini D; Franco P; Pasinetti N; Lancellotta V; Giacobazzi P; La Rocca E; D'Angelo E; Lozza L; Livi L; Meattini I; Scorsetti M
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2069-2077. PubMed ID: 33387035
[TBL] [Abstract][Full Text] [Related]
15. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.
Punglia RS; Cronin AM; Uno H; Stout NK; Ozanne EM; Greenberg CC; Frank ES; Schrag D
JAMA Oncol; 2017 Jan; 3(1):101-104. PubMed ID: 27442038
[TBL] [Abstract][Full Text] [Related]
16. The problem of ductal carcinoma in situ of the breast.
Fentiman IS
Ann Chir Gynaecol; 1992; 81(4):334-6. PubMed ID: 1336650
[TBL] [Abstract][Full Text] [Related]
17. Oncoplastic breast-conserving therapy and intraoperative radiotherapy for management of carcinoma in situ of the breast: A single-center experience.
Crown A; Carlson E; Rocha FG; Grumley JW
Breast J; 2020 Dec; 26(12):2391-2394. PubMed ID: 33283376
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of treatment options for ductal carcinoma in situ of the breast.
Lawrence G
Arch Surg; 1991 Dec; 126(12):1541-2. PubMed ID: 1668780
[No Abstract] [Full Text] [Related]
19. Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series.
Leonardi MC; Corrao G; Frassoni S; Vingiani A; Dicuonzo S; Lazzeroni M; Fodor C; Morra A; Gerardi MA; Rojas DP; Dell'Acqua V; Marvaso G; Bassi FD; Galimberti VE; Veronesi P; Miglietta E; Cattani F; Zurrida S; Bagnardi V; Viale G; Orecchia R; Jereczek-Fossa BA
Radiother Oncol; 2019 Apr; 133():68-76. PubMed ID: 30935584
[TBL] [Abstract][Full Text] [Related]
20. Permanent breast seed implant for partial breast radiotherapy after partial mastectomy for favorable breast cancer: Technique, results, and applications to various seroma presentations.
Crook J; Hilts M; Batchelar D; Milette MP; Kozeniowski M; Pilote L; Pignol JP
Brachytherapy; 2019; 18(4):510-520. PubMed ID: 31109871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
